Orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, has shown positive Phase 3 results in treating type 2 ...

On the other hand, when your blood sugar levels drop too low, your pancreas releases the hormone glucagon, which raises your blood sugar levels. Some people, such as those with diabetes ...